Glenmark Pharmaceuticals Statistics
Total Valuation
BOM:532296 has a market cap or net worth of INR 747.33 billion. The enterprise value is 748.49 billion.
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Aug 31, 2026 |
Share Statistics
| Current Share Class | 282.22M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 1.24% |
| Owned by Institutions (%) | 29.07% |
| Float | 150.20M |
Valuation Ratios
The trailing PE ratio is 51.51 and the forward PE ratio is 30.29.
| PE Ratio | 51.51 |
| Forward PE | 30.29 |
| PS Ratio | 4.67 |
| PB Ratio | 6.67 |
| P/TBV Ratio | 8.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 184.01 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 51.57 |
| EV / Sales | 4.68 |
| EV / EBITDA | 22.49 |
| EV / EBIT | 27.67 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.69 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.42 |
| Debt / FCF | n/a |
| Interest Coverage | 13.40 |
Financial Efficiency
Return on equity (ROE) is 13.96% and return on invested capital (ROIC) is 21.21%.
| Return on Equity (ROE) | 13.96% |
| Return on Assets (ROA) | 7.18% |
| Return on Invested Capital (ROIC) | 21.21% |
| Return on Capital Employed (ROCE) | 19.47% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.44M |
| Profits Per Employee | 856,446 |
| Employee Count | 16,946 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 1.48 |
Taxes
In the past 12 months, BOM:532296 has paid 4.52 billion in taxes.
| Income Tax | 4.52B |
| Effective Tax Rate | 23.76% |
Stock Price Statistics
The stock price has increased by +43.90% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +43.90% |
| 50-Day Moving Average | 2,400.36 |
| 200-Day Moving Average | 2,266.41 |
| Relative Strength Index (RSI) | 66.49 |
| Average Volume (20 Days) | 33,691 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532296 had revenue of INR 159.97 billion and earned 14.51 billion in profits. Earnings per share was 51.41.
| Revenue | 159.97B |
| Gross Profit | 107.86B |
| Operating Income | 27.05B |
| Pretax Income | 19.03B |
| Net Income | 14.51B |
| EBITDA | 32.09B |
| EBIT | 27.05B |
| Earnings Per Share (EPS) | 51.41 |
Full Income Statement Balance Sheet
The company has 12.91 billion in cash and 14.07 billion in debt, with a net cash position of -1.17 billion.
| Cash & Cash Equivalents | 12.91B |
| Total Debt | 14.07B |
| Net Cash | -1.17B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 112.12B |
| Book Value Per Share | 397.29 |
| Working Capital | 52.07B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 4.06 billion and capital expenditures -12.33 billion, giving a free cash flow of -8.26 billion.
| Operating Cash Flow | 4.06B |
| Capital Expenditures | -12.33B |
| Depreciation & Amortization | 5.03B |
| Net Borrowing | -2.04B |
| Free Cash Flow | -8.26B |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 67.42%, with operating and profit margins of 16.91% and 9.07%.
| Gross Margin | 67.42% |
| Operating Margin | 16.91% |
| Pretax Margin | 11.90% |
| Profit Margin | 9.07% |
| EBITDA Margin | 20.06% |
| EBIT Margin | 16.91% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 14.63% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.09% |
| Earnings Yield | 1.94% |
| FCF Yield | -1.11% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Analyst Forecast
The average price target for BOM:532296 is 2,703.09, which is 2.08% higher than the current price. The consensus rating is "Buy".
| Price Target | 2,703.09 |
| Price Target Difference | 2.08% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 8.03% |
| EPS Growth Forecast (3Y) | 2.24% |
Stock Splits
The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.
| Last Split Date | Sep 10, 2007 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |